Global dermatology manufacturer serving 100M+ patients across 70+ countries
LEO Pharma is a century-old Danish pharma company operating at scale (4,000 employees, 70+ country footprint) with a specialized focus on medical dermatology. The tech stack reflects a regulated, sales-and-operations-driven business: Veeva (clinical/regulatory), Salesforce (CRM), SAP (ERP), ServiceNow (case management), plus analytics depth (Power BI, Tableau, Qlik, dbt, Snowflake) — indicating significant investment in sales trending and supply-chain visibility. Active hiring across sales (52 roles), healthcare delivery, and regulatory positions signals geographic expansion and portfolio growth.
Notable leadership hires: Regulatory Strategy Director, Business Unit Director, Regulatory Advertising Director, Medical Director, Finance Director
LEO Pharma develops and markets innovative dermatological treatments, serving nearly 100 million patients annually across more than 70 countries. The company is structured around multi-regional account management, clinical education, and hospital product placement, with notable strength in critical care and specialty dermatology portfolios. Ownership is split between the LEO Foundation (majority) and Nordic Capital (since 2021), positioning it as a stable, long-term player in regulated pharma. Current operational focus spans compliance with GxP and global regulatory standards, supply-chain risk monitoring, and expansion of prescriber adoption in key markets.
Core systems include Veeva (regulatory/clinical), Salesforce (CRM), SAP (ERP), ServiceNow (operations), plus analytics platforms (Power BI, Tableau, Qlik, Snowflake, dbt). Infrastructure relies on Azure AD, AWS, and vSphere.
Ballerup, Denmark. The company operates across 70+ countries with active hiring in 15+ regions including US, Germany, Spain, Brazil, and China.
Other companies in the same industry, closest in size